Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-72.36	41.45	149.98
Graham Fair Price	41.50	0.15	0.10
PEG	-82.00	-0.15	0.85
Price/Book	-30.37	1.57	2.25
Price/Cash Flow	68.65	-26.77	-85.39
Prices/Earnings	65.19	-15.85	-45.54
Price/Sales	-65.19	1.05	3.01
Price/FCF	68.65	-26.77	-85.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-17.25	0.10	0.12
Operating Margin	< 0.005	< 0.005	< 0.005
ROA	-100.00	-0.02	< 0.005
ROE	-0.01	-0.02	-100.00
ROIC	< 0.005	< 0.005	-99.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.02	1.09
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.67	-1.00	50.24
EPS QOQ	0.54	-1.04	93.45
FCF QOQ	0.66	-1.22	86.37
Revenue QOQ	-0.42	1.00	140.96
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.68	23.78	-51.14
Days Sales Outstanding (DSO)	15.88	9.60	-39.55
Inventory Turnover	1.85	3.78	104.69
Debt/Capitalization	0.16	0.16	1.83
Quick Ratio	1.78	1.84	3.30
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.20	0.20	0.05
Cash	0.14	0.14	0.05
Capex	< 0.005	< 0.005	-100.11
Free Cash Flow	< 0.005	-0.01	-122.24
Revenue	0.15	0.30	100.11
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.59	2.59	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-41.58	-18.55	55.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating